ClassID:

116202

C12Y301/01034 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Lipoprotein lipase (3.1.1.34)

Recent Application in this class:
#1
20230265413
2023-08-24

COMPOSITIONS AND METHODS FOR ENZYME IMMOBILIZATION

#2
20230234995
2023-07-27

CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME

#3
20220282290
2022-09-08

Method for Synthesizing Diglyceride

#4
20220251172
2022-08-11

RECOMBINANTLY ENGINEERED, LIPASE/ESTERASE-DEFICIENT MAMMALIAN CELL LINES

#5
20220193129
2022-06-23

B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF

#6
20220025344
2022-01-27

LPL-GPIHBP1 FUSION POLYPEPTIDES

#7
20200123527
2020-04-23

Compositions and methods for enzyme immobilization

#8
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

#9
20190390181
2019-12-26

Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia

#10
20180179574
2018-06-28

SYSTEMS AND METHODS FOR CHARACTERIZATION OF HYPERTRIGLYCERIDEMIA

#11
20180179545
2018-06-28

Reduction of lipase activity in product formulations

#12
20180011094
2018-01-11

LPL/RLP FOR ASSESSMENT OF CARDIOVASCULAR DISEASE RISK

#13
20170202929
2017-07-20

LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITIS

#14
20160312226
2016-10-27

Reduction of lipase activity in product formulations

#15
20160051637
2016-02-25

Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis

#16
20150030581
2015-01-29

LPL variant therapeutics

#17
20150017148
2015-01-15

Netrin loop peptide mimetics and uses thereof

#18
20120328736
2012-12-27

Enzymatic Pretreatment For Making Dried Fruits

#19
20110214195
2011-09-01

Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity

#20
20110201673
2011-08-18

LPL VARIANT THERAPEUTICS

#21
20110081332
2011-04-07

TREATMENT OF NON-ALCOHOLIC STEATOTIC HEPATITIS (NASH)

#22
20090257981
2009-10-15

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

#23
20080280823
2008-11-13

Treatment of Non-Alcoholic Steatotic Hepatitis (Nash)

#24
20050163754
2005-07-28

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

#25
20050129724
2005-06-16

Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions